About this episode
Rajesh Kumar discusses the rapid evolution of the global healthcare industry, focusing on anti-obesity drugs and the impact of AI.
From the rise of anti-obesity drugs to the impact of AI, Rajesh Kumar, Senior Global Life Sciences & Healthcare Analyst, looks at how the global healthcare industry is evolving at pace. Click here for appropriate Disclosures, including analyst certifications, and Disclaimers that must be viewed with this podcast: https://www.research.hsbc.com/R/101/zWdnMjW Stay connected and access free to view reports and videos from HSBC Global Investment Research follow us on LinkedIn https://www.linkedin.com/feed/hashtag/hsbcresearch/ or click here: https://www.gbm.hsbc.com/insights/global-research
People in this episode
Guest: Rajesh Kumar
Topics covered
- healthcare
- anti-obesity drugs
- AI in healthcare
- global healthcare industry
- life sciences
Keywords
- healthcare
- anti-obesity drugs
- AI
- global healthcare
- life sciences
Mentioned in this episode
Organizations: HSBC, HSBC Global Investment Research, LinkedIn
More episodes of HSBC Global Viewpoint
- Under the Banyan Tree – Unexpected moves in Asian FX · June 12, 2026 · 13 min
- Perspectives: The evolution of the London Stock Exchange · June 10, 2026 · 26 min
- Perspectives: The confluence of TradFi and DeFi · June 8, 2026 · 21 min
- The Macro Brief – State of US tariffs · June 5, 2026 · 14 min
- Under the Banyan Tree - China's urbanisation 2.0 · June 5, 2026 · 14 min
- Perspectives: Trust and leadership in the age of AI · June 3, 2026 · 17 min
Explore listener stats, chart rankings, contacts and more on the HSBC Global Viewpoint podcast page.